Диссертация (1140650), страница 19
Текст из файла (страница 19)
‒ 2014. ‒ Vol. 12 Suppl 1. ‒ P. s229-234.76.Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an updatewith relevance for clinical practice // Lancet. ‒ 2011. ‒ Vol. 377, № 9783. ‒ P. 21152126.77.Bondeson J. Are we moving in the right direction with osteoarthritisdrug discovery? // Expert Opin Ther Targets. ‒ 2011. ‒ Vol. 15, № 12. ‒ P. 13551368.78.Bondeson J., Blom A.B., Wainwright S. et al. The role of synovialmacrophages and macrophage-produced mediators in driving inflammatory and118destructive responses in osteoarthritis // Arthritis Rheum. ‒ 2010. ‒ Vol. 62, № 3.
‒P. 647-657.79.Braun H.J., Kim H.J., Chu C.R. et al. The effect of platelet-rich plasmaformulations and blood products on human synoviocytes: implications for intraarticular injury and therapy // Am J Sports Med. ‒ 2014. ‒ Vol. 42, № 5. ‒ P. 12041210.80.Briggs K.K., Matheny L.M., Steadman J.R. Can Hylan G-F 20 withcorticosteroid meet the expectations of osteoarthritis patients? // Am J Orthop (BelleMead NJ).
‒ 2012. ‒ Vol. 41, № 7. ‒ P. 311-315.81.Burleigh A., Chanalaris A., Gardiner M.D. et al. Joint immobilizationprevents murine osteoarthritis and reveals the highly mechanosensitive nature ofprotease expression in vivo // Arthritis Rheum. ‒ 2012. ‒ Vol. 64, № 7.
‒ P. 22782288.82.Çalış H.T., Sutbeyaz S.T., Guler E. et al. Efficacy of intra-articularautologous platelet rich plasma application in knee osteoarthritis // Arch. Rheumatol.- 2015. – Vol.30. – P.198–205.83.Campbell K.A., Saltzman B.M., Mascarenhas R. et al. Does Intra-articular Platelet-Rich Plasma Injection Provide Clinically Superior OutcomesCompared With Other Therapies in the Treatment of Knee Osteoarthritis? ASystematic Review of Overlapping Meta-analyses // Arthroscopy. ‒ Epub. 2015.May 29.84.Cavallo C., Filardo G., Mariani E.
et al. Comparison of platelet-richplasma formulations for cartilage healing: an in vitro study // J Bone Joint Surg Am.‒ 2014. ‒ Vol. 96, № 5. ‒ P. 423-429.85.Cervelli V., Lucarini L., Spallone D. et al. Use of platelet-rich plasmaand hyaluronic acid in the loss of substance with bone exposure // Adv Skin WoundCare. ‒ 2011. ‒ Vol. 24, № 4. ‒ P. 176-181.86.Cerza F., Carni S., Carcangiu A. et al. Comparison between hyaluronicacid and platelet-rich plasma, intra-articular infiltration in the treatment ofgonarthrosis // Am J Sports Med. ‒ 2012.
‒ Vol. 40, № 12. ‒ P. 2822-2827.11987.Chang K.V., Hung C.Y., Aliwarga F. et al. Comparative effectivenessof platelet-rich plasma injections for treating knee joint cartilage degenerativepathology: a systematic review and meta-analysis // Arch Phys Med Rehabil. ‒ 2014.‒ Vol. 95, № 3. ‒ P. 562-575.88.Chatterjee M., Huang Z., Zhang W. et al. Distinct platelet packaging,release, and surface expression of proangiogenic and antiangiogenic factors ondifferent platelet stimuli // Blood.
‒ 2011. ‒ Vol. 117, № 14. ‒ P. 3907-3911.89.Chen W.H., Lo W.C., Hsu W.C. et al. Synergistic anabolic actions ofhyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritistherapy // Biomaterials. ‒ 2014. ‒ Vol. 35, № 36. ‒ P. 9599-9607.90.Chien C.S., Ho H.O., Liang Y.C. et al. Incorporation of exudates ofhuman platelet-rich fibrin gel in biodegradable fibrin scaffolds for tissue engineeringof cartilage // J Biomed Mater Res B Appl Biomater. ‒ 2012. ‒ Vol.
100, № 4. ‒ P.948-55.91.Civinini R., Nistri L., Martini C. et al. Growth factors in the treatmentof early osteoarthritis // Clin Cases Miner Bone Metab. ‒ 2013. ‒ Vol. 10, № 1. ‒ P.26-9.92.Colen S., van den Bekerom M.P., Mulier M. et al. Hyaluronic acid inthe treatment of knee osteoarthritis: a systematic review and meta-analysis withemphasis on the efficacy of different products // BioDrugs. ‒ 2012.
‒ Vol. 26, № 4.‒ P. 257-68.93.Coudriet G.M., He J., Trucco M. et al. Hepatocyte growth factormodulates interleukin-6 production in bone marrow derived macrophages:implications for inflammatory mediated diseases // PLoS One. ‒ 2010. ‒ Vol. 5, №11. ‒ P. e15384.94.Curran M.P. Hyaluronic acid (Supartz(R)): a review of its use inosteoarthritis of the knee // Drugs Aging. ‒ 2010.
‒ Vol. 27, № 11. ‒ P. 925-941.95.Dallari D., Stagni C., Rani N. et al. Ultrasound-Guided Injectionof Platelet-Rich Plasma and Hyaluronic Acid, Separately and in Combination, for120Hip Osteoarthritis: A Randomized Controlled Study // Am. J. Sports Med. - 2016. Jan 21. [Epub ahead of print]96.de Vries-van Melle M.L., Narcisi R., Kops N. et al. Chondrogenesis ofmesenchymal stem cells in an osteochondral environment is mediated by thesubchondral bone // Tissue Eng Part A.
‒ 2014. ‒ Vol. 20, № 1-2. ‒ P. 23-33.97.DeLong J.M., Russell R.P., Mazzocca A.D. Platelet-rich plasma: thePAW classification system // Arthroscopy. ‒ 2012. ‒ Vol. 28, № 7. ‒ P. 998-1009.98.Divine J.G., Zazulak B.T., Hewett T.E. Viscosupplementation for kneeosteoarthritis: a systematic review // Clin Orthop Relat Res.
‒ 2007. ‒ Vol. 455. ‒ P.113-122.99.Dohan Ehrenfest D.M., Andia I., Zumstein M.A. et al. Classification ofplatelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) fortopical and infiltrative use in orthopedic and sports medicine: current consensus,clinical implications and perspectives // Muscles Ligaments Tendons J. ‒ 2014. ‒Vol.
4, № 1. ‒ P. 3-9.100. Dohan Ehrenfest D.M., Rasmusson L., Albrektsson T. Classification ofplatelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- andplatelet-rich fibrin (L-PRF) // Trends Biotechnol. ‒ 2009. ‒ Vol. 27, № 3. ‒ P. 158167.101. Dold A.P., Zywiel M.G., Taylor D.W. et al. Platelet-rich plasma in themanagement of articular cartilage pathology: a systematic review // Clin J SportMed. ‒ 2014. ‒ Vol. 24, № 1. ‒ P. 31-43.102. Drengk A., Zapf A., Sturmer E.K.
et al. Influence of platelet-richplasma on chondrogenic differentiation and proliferation of chondrocytes andmesenchymal stem cells // Cells Tissues Organs. ‒ 2009. ‒ Vol. 189, № 5. ‒ P. 317326.103. Duif C., Vogel T., Topcuoglu F. et al. Does intraoperative applicationof leukocyte-poor platelet-rich plasma during arthroscopy for knee degenerationaffect postoperative pain, function and quality of life? A 12-month randomized121controlled double-blind trial // Arch.
Orthop. Trauma Surg. – 2015. – Vol. 135 (7).– P.971-977.104. El-Sharkawy H., Kantarci A., Deady J. et al. Platelet-rich plasma:growth factors and pro- and anti-inflammatory properties // J Periodontol. ‒ 2007. ‒Vol. 78, № 4. ‒ P. 661-669.105. Eppley B.L., Woodell J.E., Higgins J. Platelet quantification andgrowth factor analysis from platelet-rich plasma: implications for wound healing //Plast Reconstr Surg.
‒ 2004. ‒ Vol. 114, № 6. ‒ P. 1502-1508.106. Filardo G., Kon E., Di Martino A. et al. Platelet-rich plasma vshyaluronic acid to treat knee degenerative pathology: study design and preliminaryresults of a randomized controlled trial // BMC Musculoskelet Disord. ‒ 2012. ‒ Vol.13. ‒ P.
229.107. Filardo G., Kon E., Roffi A. et al. Platelet-rich plasma: why intraarticular? A systematic review of preclinical studies and clinical evidence on PRPfor joint degeneration // Knee Surg Sports Traumatol Arthrosc. ‒ 2015. – Vol.23(9).– P.2459-2474.108. Findlay D.M. Vascular pathology and osteoarthritis // Rheumatology(Oxford). ‒ 2007. ‒ Vol. 46, № 12. ‒ P.
1763-1768.109. Flad H.D., Brandt E. Platelet-derived chemokines: pathophysiologyand therapeutic aspects // Cell Mol Life Sci. ‒ 2010. ‒ Vol. 67, № 14. ‒ P. 23632386.110. Forogh B., Mianehsaz E., Shoaee S. et al. Effect of single injection ofPlatelet-Rich Plasma in comparison with corticosteroid on knee osteoarthritis: adouble-blind randomized clinical trial // J Sports Med Phys Fitness. ‒ Epub. 2015.Jul14.111. Foster T.E., Puskas B.L., Mandelbaum B.R.
et al. Platelet-rich plasma:from basic science to clinical applications // Am. J. Sports Med. – 2009. – Vol.37(11). – P.2259-2272.112. Gaissmaier C., Fritz J., Krackhardt T. et al. Effect of human plateletsupernatant on proliferation and matrix synthesis of human articular chondrocytes122in monolayer and three-dimensional alginate cultures // Biomaterials. ‒ 2005. ‒ Vol.26, № 14. ‒ P. 1953-1960.113. Ghosh P., Guidolin D.
Potential mechanism of action of intra-articularhyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? //Semin Arthritis Rheum. ‒ 2002. ‒ Vol. 32, № 1. ‒ P. 10-37.114. Gobbi A., Karnatzikos G., Mahajan V. et al. Platelet-rich plasmatreatment in symptomatic patients with knee osteoarthritis: preliminary results in agroup of active patients // Sports Health. ‒ 2012. ‒ Vol. 4, № 2. ‒ P. 162-172.115. Gobbi A., Lad D., Karnatzikos G.
The effects of repeated intra-articularPRP injections on clinical outcomes of early osteoarthritis of the knee // Knee SurgSports Traumatol Arthrosc. ‒ 2015. ‒ Vol. 23, № 8. ‒ P. 2170-2177.116. Gormeli G., Gormeli C., Ataoglu B. et al. Multiple PRP injections aremore effective than single injections and hyaluronic acid in knees withearly osteoarthritis: a randomized, double-blind, placebo-controlled trial //Knee Surg. Sports Traumatol.
Arthrosc. - 2015. - Aug 2. [Epub ahead of print]117. Grimaud E., Heymann D., Redini F. Recent advances in TGF-betaeffects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta incartilage disorders // Cytokine Growth Factor Rev. ‒ 2002. ‒ Vol. 13, № 3. ‒ P. 241257.118. Guillemin F., Rat A.C., Roux C.H. et al. The KHOALA cohort of kneeand hip osteoarthritis in France // Joint Bone Spine. ‒ 2012.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
